Showing results (51-60 of 74) with videos related to
Sort By:
Pageof 8
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 13, 2015
Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease PatientsAyal Hirsch, Andres J Yarur, Hou Dezheng, et al.Surgical Endoscopy|April 1, 2010
Minimally invasive colorectal resection for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may transiently inhibit VEGF-mediated angiogenesis (via altered blood levels of free Ang-1 and Ang-2)H M C Shantha Kumara, Michael J Grieco, Xiaohong Yan, et al.Surgical Endoscopy|November 16, 2011
Plasma from the second and third weeks after open colorectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasionH M C Shantha Kumara, Daniel Kirchoff, Samer Naffouje, et al.Proceedings (Baylor University. Medical Center)|June 19, 2023
Predictive factors of first-time failure on the American Board of Colorectal Surgery certifying and qualifying examinationsLucas Fair, Benjamin Gough, Neil Hyman, et al.Inflammatory Bowel Diseases|February 21, 2018
The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's DiseaseAkihiro Yamada, Yuga Komaki, Nayan Patel, et al.Digestive Diseases and Sciences|June 13, 2019
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory PouchitisJacob E Ollech, David T Rubin, Laura Glick, et al.Alimentary Pharmacology & Therapeutics|May 9, 2020
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel diseaseJingzhou Wang, Joshua Prenner, Wenfei Wang, et al.Crohn'S & Colitis 360|February 13, 2023
Low Skeletal Muscle Index Adjusted for Body Mass Index Is an Independent Risk Factor for Inflammatory Bowel Disease Surgical ComplicationsMatthew Berger, Akihiro Yamada, Yuga Komaki, et al.Diseases of the Colon and Rectum|May 6, 2005
Practice parameters for the management of rectal cancer (revised)Joe J Tjandra, John W Kilkenny, W Donald Buie, et al.Journal of Gastroenterology and Hepatology|June 7, 2019
Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remissionYunwei Wang, Jennifer Wang, Joel Pekow, et al.Pageof 8